NCT00148343

Brief Summary

The objective of this research is to determine if electrical stimulation can improve the strength and coordination of the lower limb muscles, and the walking ability of stroke survivors. The knowledge gained from this study may lead to enhancements in the quality of life of stroke survivors by improving their neurological recovery and mobility. The results may lead to substantial changes in the standard of care for the treatment of lower limb hemiparesis after stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Jul 2005

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2005

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2010

Completed
7.8 years until next milestone

Results Posted

Study results publicly available

June 1, 2018

Completed
Last Updated

June 1, 2018

Status Verified

May 1, 2018

Enrollment Period

5.1 years

First QC Date

September 2, 2005

Results QC Date

March 2, 2018

Last Update Submit

May 29, 2018

Conditions

Keywords

hemiplegiahemiparesisstrokefoot-dropelectrical stimulationankle-foot-orthosis

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Motor Assessment (FMA)

    Lower limb motor impairment as measured by the lower limb portion of the Fugl-Meyer Assessment (FMA) which consists of 17 items, with a maximum possible score of 34 points, with lower scores indicating higher impairment. Each item was answered using a 3-point ordinal scale (0 = cannot perform, 1 = can partially perform, 2 = can fully perform).

    Weeks 0, 12, 24, 36

Secondary Outcomes (4)

  • Steps Per Minute

    Weeks 0, 12, 24, 36

  • Modified Emory Functional Ambulation Profile(mEFAP)

    Weeks 0, 12, 24, 36

  • Stroke-Specific Quality of Life Scale (SS-QOL)

    Weeks 0, 12, 24, 36

  • Gait Speed

    baseline, 12, 24 and 36 weeks

Study Arms (2)

ODFS

EXPERIMENTAL

Odstock Dropped-Foot Stimulator (ODFS)

Device: Odstock Dropped-Foot Stimulator (ODFS)Procedure: Traditional Physical Therapy Treatment

Standard of Care (inc. AFO)

ACTIVE COMPARATOR

Conventional Standard of Care (which may include a study-specific Custom Molded Hinged Ankle Foot Orthosis (AFO)) \[Traditional Physical Therapy Treatment\]

Other: Conventional Standard of CareProcedure: Traditional Physical Therapy Treatment

Interventions

Device implementation \& use for \~13 weeks (until 2nd Outcomes Assessment (1st post-treatment Outcomes Assessment)). The ODFS then will be returned to the investigators.

ODFS

Conventional standard of care (which may include implementation \& use of a study-specific Custom Molded Hinged Ankle Foot Orthosis (AFO)) for \~13 weeks (until 2nd Outcomes Assessment (1st post-treatment Outcomes Assessment)). The AFO, if implemented, may continue to be used afterwards since it is an element of the standard of care for this patient population.

Standard of Care (inc. AFO)

Traditional physical therapy treatment for 12 weeks.

ODFSStandard of Care (inc. AFO)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke survivors \>90 days from most recent clinical hemorrhagic or nonhemorrhagic stroke
  • Age: 18-80 years
  • Unilateral hemiparesis
  • Medically stable
  • Sufficient endurance \& motor ability to ambulate at least 30 feet continuously with minimal assistance \[requiring contact guard to no more than 25% physical help\] or less without the use of an AFO
  • Berg Balance Scale score of 24 or greater without any assistive devices
  • Ankle dorsiflexion strength of no greater than 4/5 on the Medical Research Council (MRC) scale while standing
  • Demonstrate foot-drop during ambulation such that gait instability \[need for supervision, physical assistance or assistive device (cane, walker) to maintain balance or prevent falls\] or inefficient gait patterns \[gait pattern manifesting "dragging" or "catching" of the affected toes during swing phase of gait, or use of compensatory strategies such as circumducting the affected limb, vaulting with the unaffected limb or hiking the affected hip to clear the toes\] are exhibited
  • Ankle dorsiflexion to at least neutral while standing in response to NMES of the common peroneal nerve without painful hypersensitivity to the NMES
  • If using an AFO, willing to terminate its use and comply with study requirements

You may not qualify if:

  • Require an AFO to maintain knee stability (prevention of knee flexion collapse) during stance phase of gait
  • Edema of the affected lower limb which interferes with the safe and effective use of a peroneal nerve stimulator
  • Skin breakdown of the affected lower limb which interferes with the safe and effective use of a peroneal nerve stimulator
  • Absent sensation of the affected lower limb
  • History of potentially fatal cardiac arrhythmias, such as ventricular tachycardia, supraventricular tachycardia, and rapid ventricular response atrial fibrillation with hemodynamic instability
  • Demand pacemakers or any other implanted electronic systems
  • Pregnant women
  • Uncontrolled seizure disorder
  • Parkinson's Disease
  • Spinal cord injury
  • Traumatic brain injury with evidence of motor weakness
  • Multiple sclerosis
  • Fixed ankle plantar flexor contracture
  • Peroneal nerve injury at the fibular head as the cause of foot-drop
  • Uncompensated hemineglect
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MetroHealth Medical Center

Cleveland, Ohio, 44109, United States

Location

Related Publications (33)

  • Burridge JH, Taylor PN, Hagan SA, Wood DE, Swain ID. The effects of common peroneal stimulation on the effort and speed of walking: a randomized controlled trial with chronic hemiplegic patients. Clin Rehabil. 1997 Aug;11(3):201-10. doi: 10.1177/026921559701100303.

    PMID: 9360032BACKGROUND
  • Burridge J, Taylor P, Hagan S, Swain I. Experience of clinical use of the Odstock dropped foot stimulator. Artif Organs. 1997 Mar;21(3):254-60. doi: 10.1111/j.1525-1594.1997.tb04662.x.

    PMID: 9148719BACKGROUND
  • Burridge JH, McLellan DL. Relation between abnormal patterns of muscle activation and response to common peroneal nerve stimulation in hemiplegia. J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):353-61. doi: 10.1136/jnnp.69.3.353.

    PMID: 10945810BACKGROUND
  • Burridge JH, Wood DE, Taylor PN, McLellan DL. Indices to describe different muscle activation patterns, identified during treadmill walking, in people with spastic drop-foot. Med Eng Phys. 2001 Jul;23(6):427-34. doi: 10.1016/s1350-4533(01)00061-3.

    PMID: 11551819BACKGROUND
  • Taylor PN, Burridge JH, Dunkerley AL, Wood DE, Norton JA, Singleton C, Swain ID. Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking. Arch Phys Med Rehabil. 1999 Dec;80(12):1577-83. doi: 10.1016/s0003-9993(99)90333-7.

    PMID: 10597809BACKGROUND
  • Taylor PN, Burridge JH, Dunkerley AL, Lamb A, Wood DE, Norton JA, Swain ID. Patients' perceptions of the Odstock Dropped Foot Stimulator (ODFS). Clin Rehabil. 1999 Oct;13(5):439-46. doi: 10.1191/026921599677086409.

    PMID: 10498351BACKGROUND
  • Taylor P, Burridge J. Functional Electrical Stimulation - the Odstock Dropped Foot Stimulator. In: Sassoon R, ed. Understanding Stroke: Pardoe Blacker Publishing Ltd, 2002:72-78.

    BACKGROUND
  • Taylor P. The use of electrical stimulation for correction of dropped foot in subjects with upper motor neuron lesions. Advances in Clinical Neurosciences and Rehabilitation 2002; 2:16-18.

    BACKGROUND
  • Chae J, Bethoux F, Bohine T, Dobos L, Davis T, Friedl A. Neuromuscular stimulation for upper extremity motor and functional recovery in acute hemiplegia. Stroke. 1998 May;29(5):975-9. doi: 10.1161/01.str.29.5.975.

    PMID: 9596245BACKGROUND
  • Francisco G, Chae J, Chawla H, Kirshblum S, Zorowitz R, Lewis G, Pang S. Electromyogram-triggered neuromuscular stimulation for improving the arm function of acute stroke survivors: a randomized pilot study. Arch Phys Med Rehabil. 1998 May;79(5):570-5. doi: 10.1016/s0003-9993(98)90074-0.

    PMID: 9596400BACKGROUND
  • Mann GE, Wright PA, Swain ID. Training effects of electrical stimulation and the conventional ankle foot orthosis in the correction of drop foot following stroke., 1st Annual Conference of FESnet, 2002.

    BACKGROUND
  • Taylor P, Mann G, Swain I. Does prior use of an Ankle Foot Orthosis (AFO) effect the response to use of the Odstock Dropped Foot Stimulator?, Institute of Physics and Engineering in Medicine (IPEM) Annual Scientific Meeting, Bath, U.K., September 15-17, 2003:89-90.

    BACKGROUND
  • Buurke JH, Roetenberg D, Kleissen RFM, Hermens HJ. Early recovery of gait after stroke, 3rd World Congress in Neurological Rehabilitation, Venice, Italy, April 2-6, 2002, 2002.

    BACKGROUND
  • El-Hayek K, Quinn A, Berezovskiy R, Santing J, Harley M, Chae J. Relationship between lower limb motor impairment and ambulation function among chronic stroke survivors. Submitted.

    BACKGROUND
  • Teasell RW, Bhogal SK, Foley NC, Speechley MR. Gait retraining post stroke. Top Stroke Rehabil. 2003 Summer;10(2):34-65. doi: 10.1310/UDXE-MJFF-53V2-EAP0.

    PMID: 13680517BACKGROUND
  • Teasell RW, Foley NC, Bhogal SK, Speechley MR. An evidence-based review of stroke rehabilitation. Top Stroke Rehabil. 2003 Spring;10(1):29-58. doi: 10.1310/8YNA-1YHK-YMHB-XTE1.

    PMID: 12970830BACKGROUND
  • International Society for Prosthetics and Orthotics. Consensus Conference on

    BACKGROUND
  • LIBERSON WT, HOLMQUEST HJ, SCOT D, DOW M. Functional electrotherapy: stimulation of the peroneal nerve synchronized with the swing phase of the gait of hemiplegic patients. Arch Phys Med Rehabil. 1961 Feb;42:101-5. No abstract available.

    PMID: 13761879BACKGROUND
  • Waters RL, McNeal D, Perry J. Experimental correction of footdrop by electrical stimulation of the peroneal nerve. J Bone Joint Surg Am. 1975 Dec;57(8):1047-54.

    PMID: 1081538BACKGROUND
  • Waters RL, McNeal DR, Clifford B. Correction of footdrop in stroke patients via surgically implanted peroneal nerve stimulator. Acta Orthop Belg. 1984 Mar-Apr;50(2):285-95. No abstract available.

    PMID: 6741512BACKGROUND
  • Kljajic M, Malezic M, Acimovic R, Vavken E, Stanic U, Pangrsic B, Rozman J. Gait evaluation in hemiparetic patients using subcutaneous peroneal electrical stimulation. Scand J Rehabil Med. 1992 Sep;24(3):121-6.

    PMID: 1411357BACKGROUND
  • van der Aa HE, Bultstra G, Verloop AJ, Kenney L, Holsheimer J, Nene A, Hermens HJ, Zilvold G, Buschman HP. Application of a dual channel peroneal nerve stimulator in a patient with a "central" drop foot. Acta Neurochir Suppl. 2002;79:105-7. doi: 10.1007/978-3-7091-6105-0_23.

    PMID: 11974972BACKGROUND
  • Merletti R, Andina A, Galante M, Furlan I. Clinical experience of electronic peroneal stimulators in 50 hemiparetic patients. Scand J Rehabil Med. 1979;11(3):111-21.

    PMID: 315098BACKGROUND
  • Granat MH, Maxwell DJ, Ferguson AC, Lees KR, Barbenel JC. Peroneal stimulator; evaluation for the correction of spastic drop foot in hemiplegia. Arch Phys Med Rehabil. 1996 Jan;77(1):19-24. doi: 10.1016/s0003-9993(96)90214-2.

    PMID: 8554468BACKGROUND
  • Takebe K, Kukulka C, Narayan MG, Milner M, Basmajian JV. Peroneal nerve stimulator in rehabilitation of hemiplegic patients. Arch Phys Med Rehabil. 1975 Jun;56(6):237-9.

    PMID: 1079717BACKGROUND
  • Takebe K, Basmajian JV. Gait analysis in stroke patients to assess treatments of foot-drop. Arch Phys Med Rehabil. 1976 Jul;57(1):305-10.

    PMID: 1084734BACKGROUND
  • Stefancic M, Rebersek M, Merletti R. The therapeutic effects of the Ljublijana functional electrical brace. Eur Medicophys 1976; 12:1-9.

    BACKGROUND
  • Carnstam B, Larsson LE, Prevec TS. Improvement of gait following functional electrical stimulation. I. Investigations on changes in voluntary strength and proprioceptive reflexes. Scand J Rehabil Med. 1977;9(1):7-13.

    PMID: 302481BACKGROUND
  • Sullivan SB. Stroke. In: Sullivan SB, ed. Physical Rehabilitation: Assessment and Treatment. Philadelphia: F. A. Davis Company, 1994:327-360.

    BACKGROUND
  • Verbeke G, Molenbergh G. Linear mixed models for longitudinal data. New York: Springer-Verlag, 2000.

    BACKGROUND
  • Harrell FE. Regression modeling strategies. New York: Springer-Verlag, 2001.

    BACKGROUND
  • Sheffler LR, Taylor PN, Bailey SN, Gunzler DD, Buurke JH, IJzerman MJ, Chae J. Surface peroneal nerve stimulation in lower limb hemiparesis: effect on quantitative gait parameters. Am J Phys Med Rehabil. 2015 May;94(5):341-57. doi: 10.1097/PHM.0000000000000269.

  • Sheffler LR, Taylor PN, Gunzler DD, Buurke JH, Ijzerman MJ, Chae J. Randomized controlled trial of surface peroneal nerve stimulation for motor relearning in lower limb hemiparesis. Arch Phys Med Rehabil. 2013 Jun;94(6):1007-14. doi: 10.1016/j.apmr.2013.01.024. Epub 2013 Feb 8.

Related Links

MeSH Terms

Conditions

StrokeHemiplegiaParesisPeroneal Neuropathies

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular Diseases

Limitations and Caveats

1. Uneven randomization with respect to dorsiflexion status and mEFAP at baseline. 2. High drop out rate of 30% for the ODFS and 20% for usual care 3. Optimal dose and duration of treatment unknown 4. Activity monitor on ODFS and AFO not reliable

Results Point of Contact

Title
Lynne Sheffler, MD
Organization
Case Western Reserve University/MetroHealth Medcial Center

Study Officials

  • John Chae, MD

    MetroHealth Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof, Chair Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

September 2, 2005

First Posted

September 7, 2005

Study Start

July 1, 2005

Primary Completion

August 2, 2010

Study Completion

August 2, 2010

Last Updated

June 1, 2018

Results First Posted

June 1, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations